Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other leading institutions, have ...

Researchers at LLNL and collaborators have used an AI-driven platform to preemptively engineer an antibody that neutralizes a ...

A novel antiviral targeting the SARS-CoV-2 PLpro protease shows strong efficacy in a mouse model, preventing lung pathology and reducing brain dysfunction. The study provides proof-of-principle ...

COVID-19 has continued to alarm public health, and although several therapeutics and vaccines have been developed, the development of effective vaccines or antibodies is challenging due to mutations ...

Three doses of COVID-19 mRNA vaccination induce long-lasting antibody and memory B-cell responses, according to a study of ...

New research links multisystem inflammatory syndrome in children with COVID-19 to Epstein-Barr virus reactivation, revealing ...

Intelligence undermining the theory that the COVID-19 pandemic began naturally at a wet market has been buried for years ...

No increased risk for new-onset T2D was found after mild SARS-CoV-2 infection in a multiethnic Asian cohort during the ...

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

Lablab beans naturally contain an antiviral trap protein (FRIL) which binds to viruses and prevents them from spreading ...